RA CAPITAL MANAGEMENT, L.P. purchased 6.8% of their position (369K shares) of MINERALYS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $8.76M — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/31/2026ACC: 0001231919-26-000300
Director
Since Feb 2026
+369K
Net shares
Net buyer
$8.76M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
369K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+310.70K
Price / share
$23.67
Trade value
$7.35M
% of position
5.7%
3/27/2026
5.46M→5.77M
Common Stock
Indirect
Shares
+58.30K
Price / share
$24.16
Trade value
$1.41M
% of position
1.0%
3/30/2026
5.77M→5.83M
Total
Net shares
+369K
Net value
$8.76M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/27/2026 | P · Purchase | +310.70K | $23.67 | $7.35M | 5.7% | 5.46M | 5.77M |
| Common Stock Indirect | 3/30/2026 | P · Purchase | +58.30K | $24.16 | $1.41M | 1.0% | 5.77M | 5.83M |
| Total | +369K | $8.76M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.87M
Total
1.87M indirect1.87M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.87M | Indirect |
| Total | 1.87M | 1.87M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported